Gonzalo
Fernández Hinojal
Colaborador Médico
Hospital Virgen del Camino
Pamplona, EspañaPublicaciones en colaboración con investigadores/as de Hospital Virgen del Camino (8)
2022
-
The multi-specific VH-based Humabody CB213 co-targets PD1 and LAG3 on T cells to promote anti-tumour activity
British Journal of Cancer, Vol. 126, Núm. 8, pp. 1168-1177
2021
-
A proteomic atlas of lineage and cancer-polarized expression modules in myeloid cells modeling immunosuppressive tumor-infiltrating subsets
Journal of Personalized Medicine, Vol. 11, Núm. 6
-
Understanding lag-3 signaling
International Journal of Molecular Sciences, Vol. 22, Núm. 10
2020
-
PD-L1 in systemic immunity: Unraveling its contribution to PD-1/PD-L1 blockade immunotherapy
International Journal of Molecular Sciences, Vol. 21, Núm. 16, pp. 1-17
-
Systemic blood immune cell populations as biomarkers for the outcome of immune checkpoint inhibitor therapies
International Journal of Molecular Sciences, Vol. 21, Núm. 7
2019
-
PD-L1 expression in systemic immune cell populations as a potential predictive biomarker of responses to PD-L1/PD-1 blockade therapy in lung cancer
International Journal of Molecular Sciences, Vol. 20, Núm. 7
2017
-
PD-L1 signal transduction mechanisms in cancer cells
Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry, Vol. 17, Núm. 2, pp. 72-86
-
PDL1 Signals through Conserved Sequence Motifs to Overcome Interferon-Mediated Cytotoxicity
Cell Reports, Vol. 20, Núm. 8, pp. 1818-1829